VFC
79
2
SLB
48
2
ROP
50
3
MU
55
-5
NRG
52
-8
DLTR
66
4
VNO
49
8
PFG
67
2
TRIP
60
2
MMM
61
-2
SEE
55
5
AVGO
31
5
MAR
59
-6
ALL
53
-4
AMAT
54
-3
NKE
42
2
CME
45
-3
PHM
57
-2
MDT
60
-3
UNM
53
3
VFC
79
2
SLB
48
2
ROP
50
3
MU
55
-5
NRG
52
-8
DLTR
66
4
VNO
49
8
PFG
67
2
TRIP
60
2
MMM
61
-2
SEE
55
5
AVGO
31
5
MAR
59
-6
ALL
53
-4
AMAT
54
-3
NKE
42
2
CME
45
-3
PHM
57
-2
MDT
60
-3
UNM
53
3
Financhill
Back

Design Therapeutics, Inc. 10K Form

Buy
72

DSGN
Design Therapeutics, Inc.

Last Price:
$9.82
Seasonality Move:
-15.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DSGN News And Ratings

See the #1 stock for the next 7 days that we like better than DSGN

DSGN Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-11.2M
Price / Cash Flow: 0
Annual Sales: $3.51
Price / Book: 2.79

Profitability

EPS (TTM): -1.18690
Net Income (TTM): $-67.4M
Gross Margin: $-596K
Return on Equity: -29.71%
Return on Assets: -28.44%

Design Therapeutics, Inc. Earnings Forecast

Key Design Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 6 years have been positive in 1 years.

Design Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DSGN
Website: designtx.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 18.71
Quick Ratio: 18.43

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DSGN Technical Analysis vs Fundamental Analysis

Buy
72
Design Therapeutics, Inc. (DSGN) is a Buy

Is Design Therapeutics, Inc. a Buy or a Sell?